Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $4.46 Million - $5.12 Million
172,100 New
172,100 $4.78 Million
Q2 2023

Aug 09, 2023

BUY
$36.12 - $41.79 $1.41 Million - $1.63 Million
38,900 Added 22.08%
215,100 $7.89 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $649,935 - $846,120
16,500 Added 10.33%
176,200 $7.19 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $2.81 Million - $3.67 Million
-67,400 Reduced 29.68%
159,700 $8.18 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $2.81 Million - $3.43 Million
-64,200 Reduced 22.04%
227,100 $9.94 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $2.78 Million - $3.3 Million
-59,800 Reduced 17.03%
291,300 $15.3 Million
Q4 2021

Feb 15, 2022

BUY
$41.32 - $61.25 $214,864 - $318,500
5,200 Added 1.5%
351,100 $20.7 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $1.13 Million - $1.45 Million
-28,700 Reduced 7.66%
345,900 $14.9 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $1.63 Million - $1.85 Million
45,400 Added 13.79%
374,600 $14.7 Million
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $385,135 - $434,355
-11,500 Reduced 3.38%
329,200 $11.9 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $7.46 Million - $9.49 Million
222,900 Added 189.22%
340,700 $12.5 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $409,575 - $480,525
-12,900 Reduced 9.87%
117,800 $4.32 Million
Q2 2020

Aug 06, 2020

SELL
$30.12 - $36.54 $756,012 - $917,154
-25,100 Reduced 16.11%
130,700 $4.27 Million
Q1 2020

May 13, 2020

BUY
$27.03 - $38.62 $445,995 - $637,230
16,500 Added 11.84%
155,800 $5.09 Million
Q4 2019

Feb 10, 2020

BUY
$32.92 - $37.36 $1.28 Million - $1.45 Million
38,900 Added 38.75%
139,300 $5.46 Million
Q3 2019

Nov 19, 2019

BUY
$32.49 - $42.13 $19,494 - $25,278
600 Added 0.6%
100,400 $3.61 Million
Q2 2019

Aug 15, 2019

SELL
$36.98 - $41.52 $2.11 Million - $2.37 Million
-57,000 Reduced 36.35%
99,800 $4.32 Million
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $431,250 - $473,800
11,500 Added 7.91%
156,800 $6.66 Million
Q3 2018

Oct 16, 2018

SELL
$34.47 - $41.81 $34,470 - $41,810
-1,000 Reduced 0.68%
145,300 $6.4 Million
Q2 2018

Aug 17, 2018

SELL
$32.98 - $35.16 $237,455 - $253,151
-7,200 Reduced 4.69%
146,300 $5.31 Million
Q1 2018

Apr 10, 2018

SELL
$31.91 - $37.02 $17.8 Million - $20.7 Million
-558,887 Reduced 78.45%
153,500 $5.45 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $824,049 - $874,345
24,776 Added 3.6%
712,387 $25.8 Million
Q3 2017

Oct 31, 2017

BUY
$31.0 - $34.15 $21.3 Million - $23.5 Million
687,611
687,611 $24.5 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Andra Ap Fonden Portfolio

Follow Andra Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.